Search research articles
Contact Us
Filters
Showing results (571-580 of 613) with videos related to
Page
of 62
Sort By:
Cancer Chemotherapy and Pharmacology
|
January 19, 2017
Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer
Jeffrey R Infante, Amita Patnaik, Claire F Verschraegen, et al.
Nucleic Acids Research
|
November 12, 2023
TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells
Aruna S Jaiswal, Arijit Dutta, Gayathri Srinivasan, et al.
Elife
|
July 5, 2022
Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an <i>N</i>-of-1 clinical trial
Montaser F Shaheen, Julie Y Tse, Ethan S Sokol, et al.
Molecules (Basel, Switzerland)
|
April 30, 2021
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M<sup>pro</sup>) Inhibitors
Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Tarik A Mohamed, et al.
Cancer Research
|
June 21, 2018
Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations
Adam G Sowalsky, Huihui Ye, Manoj Bhasin, et al.
Neurosurgical Focus
|
May 1, 2024
Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection
Abdul Karim Ghaith, Ryan Nguyen, Victor Gabriel El-Hajj, et al.
JCO Precision Oncology
|
December 3, 2024
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms
Thomas J George, Ji-Hyun Lee, David L DeRemer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 21, 2025
Cognitive outcomes of deep brain stimulation depend on age and hippocampal connectivity in Parkinson's and Alzheimer's disease
Calvin W Howard, Martin Reich, Lan Luo, et al.
Journal for Immunotherapy of Cancer
|
June 12, 2021
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
Yousef Zakharia, Robert R McWilliams, Olivier Rixe, et al.
Cell
|
August 21, 2022
Post-gastrulation synthetic embryos generated ex utero from mouse naive ESCs
Shadi Tarazi, Alejandro Aguilera-Castrejon, Carine Joubran, et al.
Page
of 62
Search research articles
Search
Showing results (571-580 of 613) with videos related to
Sort By:
Page
of 62
Cancer Chemotherapy and Pharmacology
|
January 19, 2017
Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer
Jeffrey R Infante, Amita Patnaik, Claire F Verschraegen, et al.
Nucleic Acids Research
|
November 12, 2023
TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells
Aruna S Jaiswal, Arijit Dutta, Gayathri Srinivasan, et al.
Elife
|
July 5, 2022
Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an <i>N</i>-of-1 clinical trial
Montaser F Shaheen, Julie Y Tse, Ethan S Sokol, et al.
Molecules (Basel, Switzerland)
|
April 30, 2021
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M<sup>pro</sup>) Inhibitors
Mahmoud A A Ibrahim, Alaa H M Abdelrahman, Tarik A Mohamed, et al.
Cancer Research
|
June 21, 2018
Neoadjuvant-Intensive Androgen Deprivation Therapy Selects for Prostate Tumor Foci with Diverse Subclonal Oncogenic Alterations
Adam G Sowalsky, Huihui Ye, Manoj Bhasin, et al.
Neurosurgical Focus
|
May 1, 2024
Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection
Abdul Karim Ghaith, Ryan Nguyen, Victor Gabriel El-Hajj, et al.
JCO Precision Oncology
|
December 3, 2024
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms
Thomas J George, Ji-Hyun Lee, David L DeRemer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 21, 2025
Cognitive outcomes of deep brain stimulation depend on age and hippocampal connectivity in Parkinson's and Alzheimer's disease
Calvin W Howard, Martin Reich, Lan Luo, et al.
Journal for Immunotherapy of Cancer
|
June 12, 2021
Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma
Yousef Zakharia, Robert R McWilliams, Olivier Rixe, et al.
Cell
|
August 21, 2022
Post-gastrulation synthetic embryos generated ex utero from mouse naive ESCs
Shadi Tarazi, Alejandro Aguilera-Castrejon, Carine Joubran, et al.
Page
of 62